Suppr超能文献

丙型肝炎病毒通过 PKR 的激活来控制干扰素的产生。

Hepatitis C virus controls interferon production through PKR activation.

机构信息

Institut Pasteur, Unité Hépacivirus et Immunité Innée, Paris, France.

出版信息

PLoS One. 2010 May 11;5(5):e10575. doi: 10.1371/journal.pone.0010575.

Abstract

Hepatitis C virus is a poor inducer of interferon (IFN), although its structured viral RNA can bind the RNA helicase RIG-I, and activate the IFN-induction pathway. Low IFN induction has been attributed to HCV NS3/4A protease-mediated cleavage of the mitochondria-adapter MAVS. Here, we have investigated the early events of IFN induction upon HCV infection, using the cell-cultured HCV JFH1 strain and the new HCV-permissive hepatoma-derived Huh7.25.CD81 cell subclone. These cells depend on ectopic expression of the RIG-I ubiquitinating enzyme TRIM25 to induce IFN through the RIG-I/MAVS pathway. We observed induction of IFN during the first 12 hrs of HCV infection, after which a decline occurred which was more abrupt at the protein than at the RNA level, revealing a novel HCV-mediated control of IFN induction at the level of translation. The cellular protein kinase PKR is an important regulator of translation, through the phosphorylation of its substrate the eIF2alpha initiation factor. A comparison of the expression of luciferase placed under the control of an eIF2alpha-dependent (IRES(EMCV)) or independent (IRES(HCV)) RNA showed a specific HCV-mediated inhibition of eIF2alpha-dependent translation. We demonstrated that HCV infection triggers the phosphorylation of both PKR and eIF2alpha at 12 and 15 hrs post-infection. PKR silencing, as well as treatment with PKR pharmacological inhibitors, restored IFN induction in JFH1-infected cells, at least until 18 hrs post-infection, at which time a decrease in IFN expression could be attributed to NS3/4A-mediated MAVS cleavage. Importantly, both PKR silencing and PKR inhibitors led to inhibition of HCV yields in cells that express functional RIG-I/MAVS. In conclusion, here we provide the first evidence that HCV uses PKR to restrain its ability to induce IFN through the RIG-I/MAVS pathway. This opens up new possibilities to assay PKR chemical inhibitors for their potential to boost innate immunity in HCV infection.

摘要

丙型肝炎病毒(Hepatitis C virus)诱导干扰素(IFN)的能力较差,尽管其结构病毒 RNA 可以与 RNA 解旋酶 RIG-I 结合,并激活 IFN 诱导途径。低 IFN 诱导归因于 HCV NS3/4A 蛋白酶介导的线粒体接头 MAVS 的切割。在这里,我们使用细胞培养的 HCV JFH1 株和新的 HCV 允许性肝癌衍生的 Huh7.25.CD81 细胞亚克隆研究了 HCV 感染后 IFN 诱导的早期事件。这些细胞依赖于 RIG-I 泛素化酶 TRIM25 的异位表达,通过 RIG-I/MAVS 途径诱导 IFN。我们观察到在 HCV 感染的前 12 小时内诱导 IFN,之后发生下降,在蛋白质水平上的下降比在 RNA 水平上更突然,这揭示了 HCV 介导的 IFN 诱导在翻译水平上的新的控制。细胞蛋白激酶 PKR 是翻译的重要调节剂,通过其底物 eIF2alpha 起始因子的磷酸化。荧光素酶在 eIF2alpha 依赖性(IRES(EMCV))或独立(IRES(HCV))RNA 控制下的表达比较表明,HCV 特异性抑制 eIF2alpha 依赖性翻译。我们证明 HCV 感染在感染后 12 和 15 小时触发 PKR 和 eIF2alpha 的磷酸化。PKR 沉默以及用 PKR 药理学抑制剂处理恢复了 JFH1 感染细胞中的 IFN 诱导,至少在感染后 18 小时,此时 IFN 表达的下降可归因于 NS3/4A 介导的 MAVS 切割。重要的是,PKR 沉默和 PKR 抑制剂都导致表达功能性 RIG-I/MAVS 的细胞中 HCV 产量的抑制。总之,这里我们提供了第一个证据,证明 HCV 使用 PKR 来抑制其通过 RIG-I/MAVS 途径诱导 IFN 的能力。这为检测 PKR 化学抑制剂在 HCV 感染中增强先天免疫的潜力开辟了新的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2af8/2868028/7d270e20cbc1/pone.0010575.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验